21
Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100
Condition(s):Human Papillomavirus (HPV)Last Updated:August 10, 2018Completed
49 Clinical Trials Sponsored by “Inovio Pharmaceuticals”, Page 3 of 5
Hide Studies Not Open or Pending
22
Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults
Condition(s):HealthyLast Updated:September 13, 2017Completed
23
Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants
Condition(s):HIV-1 Infection; HIV InfectionsLast Updated:November 9, 2012Completed
24
Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3
Condition(s):Papillomavirus InfectionsLast Updated:September 13, 2017Completed
25
Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma
Condition(s):Head Neck CancerLast Updated:October 15, 2018Withdrawn
26
Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma
Condition(s):Head and Neck CancerLast Updated:September 29, 2017Withdrawn
27
Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
Condition(s):CancerLast Updated:October 3, 2017Completed
28
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
Condition(s):Head and Neck CancerLast Updated:October 3, 2017Completed
29
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
Condition(s):BRCA1 MutationLast Updated:April 29, 2020Not yet recruiting
30
Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Condition(s):GlioblastomaLast Updated:June 11, 2020Not yet recruiting